Pet Releaf has released Sentesa, a veterinary line of hemp-based supplements formulated to manage a dog’s inflammatory response, discomfort, calmness, joint flexibility and mobility.
Sentesa capsules contain cannabidiol (CBD), beta-caryophyllene and caprylic acid, a triglyceride.
The Denver company reported that Sentesa was “developed by veterinarians, exclusively for veterinarians.”
“We knew from our veterinary partners that there is an unmet need for data-driven product development in the hemp space,” said Alina Smith, the CEO and co-founder of Pet Releaf. “We focused on delivering products to the veterinarian that can safely and effectively manage their patient’s long-term health and well-being.”
Pet Releaf reported that it is “the first and only pet brand to receive program certifications from the three most trusted organizations in their respective industries: National Animal Supplement Council, U.S. Hemp Authority and USDA Organic on many products.”
“With the data-driven approach to development, completed safety and PK [pharmacokinetics] study, and an ongoing field safety and efficacy study, we are thrilled to offer the veterinarian a new option for the management of their patients,” said Joseph Rosentel, MS, DVM, Ph.D., Pet Releaf’s vice president of product development and supply chain.
Did you know a subscription to Today’s Veterinary Business is free to qualified veterinary professionals? All you have to do is sign up here (and renew each year). You also can sign up to receive the Today’s Veterinary Business weekly e-newsletter.